Global and Japan Vasculitis Drug Market Insights, Forecast to 2026
SKU ID : QYR-16433167 | Publishing Date : 16-Sep-2020
Detailed TOC of Global and Japan Vasculitis Drug Market Insights, Forecast to 2026
1 Study Coverage1.1 Vasculitis Drug Product Introduction
1.2 Market Segments
1.3 Key Vasculitis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Vasculitis Drug Market Size Growth Rate by Type
1.4.2 Blisibimod
1.4.3 CCX-168
1.4.4 Gevokizumab
1.4.5 Rituximab Biosimilar
1.4.6 Others
1.5 Market by Application
1.5.1 Global Vasculitis Drug Market Size Growth Rate by Application
1.5.2 Polyarteritis Nodosa
1.5.3 Thrombotic Vasculitis
1.5.4 Granulomatous Vasculitis
1.5.5 Lymphocytic Vasculitis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Vasculitis Drug Market Size, Estimates and Forecasts
2.1.1 Global Vasculitis Drug Revenue 2015-2026
2.1.2 Global Vasculitis Drug Sales 2015-2026
2.2 Global Vasculitis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Vasculitis Drug Historical Market Size by Region (2015-2020)
2.3.1 Global Vasculitis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Vasculitis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Vasculitis Drug Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Vasculitis Drug Sales Forecast by Region (2021-2026)
2.4.2 Global Vasculitis Drug Revenue Forecast by Region (2021-2026)
3 Global Vasculitis Drug Competitor Landscape by Players
3.1 Global Top Vasculitis Drug Sales by Manufacturers
3.1.1 Global Vasculitis Drug Sales by Manufacturers (2015-2020)
3.1.2 Global Vasculitis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Global Vasculitis Drug Manufacturers by Revenue
3.2.1 Global Vasculitis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Global Vasculitis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Vasculitis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Vasculitis Drug Revenue in 2019
3.2.5 Global Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Vasculitis Drug Price by Manufacturers
3.4 Global Vasculitis Drug Manufacturing Base Distribution, Product Types
3.4.1 Vasculitis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vasculitis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Vasculitis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Vasculitis Drug Market Size by Type (2015-2020)
4.1.1 Global Vasculitis Drug Sales by Type (2015-2020)
4.1.2 Global Vasculitis Drug Revenue by Type (2015-2020)
4.1.3 Vasculitis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Vasculitis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Vasculitis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Vasculitis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Vasculitis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Vasculitis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Vasculitis Drug Market Size by Application (2015-2020)
5.1.1 Global Vasculitis Drug Sales by Application (2015-2020)
5.1.2 Global Vasculitis Drug Revenue by Application (2015-2020)
5.1.3 Vasculitis Drug Price by Application (2015-2020)
5.2 Vasculitis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Vasculitis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Vasculitis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Vasculitis Drug Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Vasculitis Drug Market Size YoY Growth 2015-2026
6.1.1 Japan Vasculitis Drug Sales YoY Growth 2015-2026
6.1.2 Japan Vasculitis Drug Revenue YoY Growth 2015-2026
6.1.3 Japan Vasculitis Drug Market Share in Global Market 2015-2026
6.2 Japan Vasculitis Drug Market Size by Players (International and Local Players)
6.2.1 Japan Top Vasculitis Drug Players by Sales (2015-2020)
6.2.2 Japan Top Vasculitis Drug Players by Revenue (2015-2020)
6.3 Japan Vasculitis Drug Historic Market Review by Type (2015-2020)
6.3.1 Japan Vasculitis Drug Sales Market Share by Type (2015-2020)
6.3.2 Japan Vasculitis Drug Revenue Market Share by Type (2015-2020)
6.3.3 Japan Vasculitis Drug Price by Type (2015-2020)
6.4 Japan Vasculitis Drug Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Vasculitis Drug Sales Forecast by Type (2021-2026)
6.4.2 Japan Vasculitis Drug Revenue Forecast by Type (2021-2026)
6.4.3 Japan Vasculitis Drug Price Forecast by Type (2021-2026)
6.5 Japan Vasculitis Drug Historic Market Review by Application (2015-2020)
6.5.1 Japan Vasculitis Drug Sales Market Share by Application (2015-2020)
6.5.2 Japan Vasculitis Drug Revenue Market Share by Application (2015-2020)
6.5.3 Japan Vasculitis Drug Price by Application (2015-2020)
6.6 Japan Vasculitis Drug Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Vasculitis Drug Sales Forecast by Application (2021-2026)
6.6.2 Japan Vasculitis Drug Revenue Forecast by Application (2021-2026)
6.6.3 Japan Vasculitis Drug Price Forecast by Application (2021-2026)
7 North America
7.1 North America Vasculitis Drug Market Size YoY Growth 2015-2026
7.2 North America Vasculitis Drug Market Facts & Figures by Country
7.2.1 North America Vasculitis Drug Sales by Country (2015-2020)
7.2.2 North America Vasculitis Drug Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Vasculitis Drug Market Size YoY Growth 2015-2026
8.2 Europe Vasculitis Drug Market Facts & Figures by Country
8.2.1 Europe Vasculitis Drug Sales by Country
8.2.2 Europe Vasculitis Drug Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Vasculitis Drug Market Size YoY Growth 2015-2026
9.2 Asia Pacific Vasculitis Drug Market Facts & Figures by Country
9.2.1 Asia Pacific Vasculitis Drug Sales by Region (2015-2020)
9.2.2 Asia Pacific Vasculitis Drug Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Vasculitis Drug Market Size YoY Growth 2015-2026
10.2 Latin America Vasculitis Drug Market Facts & Figures by Country
10.2.1 Latin America Vasculitis Drug Sales by Country
10.2.2 Latin America Vasculitis Drug Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Vasculitis Drug Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Vasculitis Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Vasculitis Drug Sales by Country
11.2.2 Middle East and Africa Vasculitis Drug Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck Vasculitis Drug Products Offered
12.1.5 Merck Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Description and Business Overview
12.2.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bayer Vasculitis Drug Products Offered
12.2.5 Bayer Recent Development
12.3 Farmalider
12.3.1 Farmalider Corporation Information
12.3.2 Farmalider Description and Business Overview
12.3.3 Farmalider Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Farmalider Vasculitis Drug Products Offered
12.3.5 Farmalider Recent Development
12.4 Hainan Pharmaceutical Factory
12.4.1 Hainan Pharmaceutical Factory Corporation Information
12.4.2 Hainan Pharmaceutical Factory Description and Business Overview
12.4.3 Hainan Pharmaceutical Factory Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Hainan Pharmaceutical Factory Vasculitis Drug Products Offered
12.4.5 Hainan Pharmaceutical Factory Recent Development
12.5 Shanghaihuangxiang Lantian Pharmaceutical
12.5.1 Shanghaihuangxiang Lantian Pharmaceutical Corporation Information
12.5.2 Shanghaihuangxiang Lantian Pharmaceutical Description and Business Overview
12.5.3 Shanghaihuangxiang Lantian Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Products Offered
12.5.5 Shanghaihuangxiang Lantian Pharmaceutical Recent Development
12.6 Huzhou Konch Pharmaceutical
12.6.1 Huzhou Konch Pharmaceutical Corporation Information
12.6.2 Huzhou Konch Pharmaceutical Description and Business Overview
12.6.3 Huzhou Konch Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Huzhou Konch Pharmaceutical Vasculitis Drug Products Offered
12.6.5 Huzhou Konch Pharmaceutical Recent Development
12.7 CSPC Ouyi Pharmaceutical
12.7.1 CSPC Ouyi Pharmaceutical Corporation Information
12.7.2 CSPC Ouyi Pharmaceutical Description and Business Overview
12.7.3 CSPC Ouyi Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.7.4 CSPC Ouyi Pharmaceutical Vasculitis Drug Products Offered
12.7.5 CSPC Ouyi Pharmaceutical Recent Development
12.8 Sino-US Zibo Xinhua-Perrigo Pharmaceutical
12.8.1 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Corporation Information
12.8.2 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Description and Business Overview
12.8.3 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Products Offered
12.8.5 Sino-US Zibo Xinhua-Perrigo Pharmaceutical Recent Development
12.9 Hubei Biocause Pharmaceutical
12.9.1 Hubei Biocause Pharmaceutical Corporation Information
12.9.2 Hubei Biocause Pharmaceutical Description and Business Overview
12.9.3 Hubei Biocause Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Hubei Biocause Pharmaceutical Vasculitis Drug Products Offered
12.9.5 Hubei Biocause Pharmaceutical Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Merck Vasculitis Drug Products Offered
12.11.5 Merck Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Vasculitis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Vasculitis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan Vasculitis Drug Market Insights, Forecast to 2026
List of TablesTable 1. Vasculitis Drug Market Segments
Table 2. Ranking of Global Top Vasculitis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Vasculitis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Blisibimod
Table 5. Major Manufacturers of CCX-168
Table 6. Major Manufacturers of Gevokizumab
Table 7. Major Manufacturers of Rituximab Biosimilar
Table 8. Major Manufacturers of Others
Table 9. Global Vasculitis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Vasculitis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Vasculitis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Vasculitis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Vasculitis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Vasculitis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Vasculitis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Vasculitis Drug Sales Share by Manufacturers (2015-2020)
Table 17. Global Vasculitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Vasculitis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasculitis Drug as of 2019)
Table 19. Vasculitis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Vasculitis Drug Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Vasculitis Drug Price (2015-2020) (USD/Pcs)
Table 22. Vasculitis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Vasculitis Drug Product Type
Table 24. Date of International Manufacturers Enter into Vasculitis Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Vasculitis Drug Sales by Type (2015-2020) (K Pcs)
Table 27. Global Vasculitis Drug Sales Share by Type (2015-2020)
Table 28. Global Vasculitis Drug Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Vasculitis Drug Revenue Share by Type (2015-2020)
Table 30. Vasculitis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Vasculitis Drug Sales Share by Type (2021-2026)
Table 32. Global Vasculitis Drug Sales by Application (2015-2020) (K Pcs)
Table 33. Global Vasculitis Drug Sales Share by Application (2015-2020)
Table 34. Global Vasculitis Drug Sales Share by Application (2021-2026)
Table 35. Global Vasculitis Drug Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Vasculitis Drug Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Vasculitis Drug Revenue Market Share Forecast by Application (2021-2026)
Table 38. Japan Vasculitis Drug Sales (K Pcs) of Key Companies (2015-2020)
Table 39. Japan Vasculitis Drug Sales Share by Company (2015-2020)
Table 40. Japan Vasculitis Drug Revenue (US$ Million) by Company (2015-2020)
Table 41. Japan Vasculitis Drug Sales (K Pcs) by Type (2015-2020)
Table 42. Japan Vasculitis Drug Sales Share by Type (2015-2020)
Table 43. Japan Vasculitis Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. Japan Vasculitis Drug Price (K Pcs) by Type (2015-2020)
Table 45. Japan Vasculitis Drug Sales (K Pcs) by Type (2021-2026)
Table 46. Japan Vasculitis Drug Sales Share by Type (2021-2026)
Table 47. Japan Vasculitis Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. Japan Vasculitis Drug Revenue Share by Type (2021-2026)
Table 49. Japan Vasculitis Drug Price (K Pcs) by Type (2021-2026)
Table 50. Japan Vasculitis Drug Sales (K Pcs) by Application (2015-2020)
Table 51. Japan Vasculitis Drug Sales Share by Application (2015-2020)
Table 52. Japan Vasculitis Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. Japan Vasculitis Drug Sales (K Pcs) by Application (2021-2026)
Table 54. Japan Vasculitis Drug Sales Share by Application (2021-2026)
Table 55. Japan Vasculitis Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. Japan Vasculitis Drug Revenue Share by Application (2021-2026)
Table 57. North America Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 58. North America Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 59. North America Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 61. Europe Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 63. Europe Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Vasculitis Drug Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Vasculitis Drug Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Vasculitis Drug Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Vasculitis Drug Revenue Market Share by Region (2015-2020)
Table 69. Latin America Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Vasculitis Drug Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Vasculitis Drug Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Vasculitis Drug Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Vasculitis Drug Revenue Market Share by Country (2015-2020)
Table 77. Merck Corporation Information
Table 78. Merck Description and Business Overview
Table 79. Merck Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Merck Vasculitis Drug Product
Table 81. Merck Recent Development
Table 82. Bayer Corporation Information
Table 83. Bayer Description and Business Overview
Table 84. Bayer Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Bayer Product
Table 86. Bayer Recent Development
Table 87. Farmalider Corporation Information
Table 88. Farmalider Description and Business Overview
Table 89. Farmalider Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Farmalider Product
Table 91. Farmalider Recent Development
Table 92. Hainan Pharmaceutical Factory Corporation Information
Table 93. Hainan Pharmaceutical Factory Description and Business Overview
Table 94. Hainan Pharmaceutical Factory Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Hainan Pharmaceutical Factory Product
Table 96. Hainan Pharmaceutical Factory Recent Development
Table 97. Shanghaihuangxiang Lantian Pharmaceutical Corporation Information
Table 98. Shanghaihuangxiang Lantian Pharmaceutical Description and Business Overview
Table 99. Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Shanghaihuangxiang Lantian Pharmaceutical Product
Table 101. Shanghaihuangxiang Lantian Pharmaceutical Recent Development
Table 102. Huzhou Konch Pharmaceutical Corporation Information
Table 103. Huzhou Konch Pharmaceutical Description and Business Overview
Table 104. Huzhou Konch Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Huzhou Konch Pharmaceutical Product
Table 106. Huzhou Konch Pharmaceutical Recent Development
Table 107. CSPC Ouyi Pharmaceutical Corporation Information
Table 108. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 109. CSPC Ouyi Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. CSPC Ouyi Pharmaceutical Product
Table 111. CSPC Ouyi Pharmaceutical Recent Development
Table 112. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Corporation Information
Table 113. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Description and Business Overview
Table 114. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Product
Table 116. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Recent Development
Table 117. Hubei Biocause Pharmaceutical Corporation Information
Table 118. Hubei Biocause Pharmaceutical Description and Business Overview
Table 119. Hubei Biocause Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Hubei Biocause Pharmaceutical Product
Table 121. Hubei Biocause Pharmaceutical Recent Development
Table 122. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 123. Key Challenges
Table 124. Market Risks
Table 125. Main Points Interviewed from Key Vasculitis Drug Players
Table 126. Vasculitis Drug Customers List
Table 127. Vasculitis Drug Distributors List
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Vasculitis Drug Product Picture
Figure 2. Global Vasculitis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Blisibimod Product Picture
Figure 4. CCX-168 Product Picture
Figure 5. Gevokizumab Product Picture
Figure 6. Rituximab Biosimilar Product Picture
Figure 7. Others Product Picture
Figure 8. Global Vasculitis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Polyarteritis Nodosa
Figure 10. Thrombotic Vasculitis
Figure 11. Granulomatous Vasculitis
Figure 12. Lymphocytic Vasculitis
Figure 13. Others
Figure 14. Vasculitis Drug Report Years Considered
Figure 15. Global Vasculitis Drug Market Size 2015-2026 (US$ Million)
Figure 16. Global Vasculitis Drug Sales 2015-2026 (K Pcs)
Figure 17. Global Vasculitis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Vasculitis Drug Sales Market Share by Region (2015-2020)
Figure 19. Global Vasculitis Drug Sales Market Share by Region in 2019
Figure 20. Global Vasculitis Drug Revenue Market Share by Region (2015-2020)
Figure 21. Global Vasculitis Drug Revenue Market Share by Region in 2019
Figure 22. Global Vasculitis Drug Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Vasculitis Drug Revenue in 2019
Figure 24. Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Vasculitis Drug Sales Market Share by Type (2015-2020)
Figure 26. Global Vasculitis Drug Sales Market Share by Type in 2019
Figure 27. Global Vasculitis Drug Revenue Market Share by Type (2015-2020)
Figure 28. Global Vasculitis Drug Revenue Market Share by Type in 2019
Figure 29. Global Vasculitis Drug Market Share by Price Range (2015-2020)
Figure 30. Global Vasculitis Drug Sales Market Share by Application (2015-2020)
Figure 31. Global Vasculitis Drug Sales Market Share by Application in 2019
Figure 32. Global Vasculitis Drug Revenue Market Share by Application (2015-2020)
Figure 33. Global Vasculitis Drug Revenue Market Share by Application in 2019
Figure 34. Japan Vasculitis Drug Sales Growth Rate 2015-2026 (K Pcs)
Figure 35. Japan Vasculitis Drug Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. Japan Vasculitis Drug Market Share in Global Market 2015-2026
Figure 37. Japan 5 and 10 Largest Vasculitis Drug Players Market Share by Revenue in Vasculitis Drug in 2019
Figure 38. Japan Vasculitis Drug Revenue Share by Type (2015-2020)
Figure 39. Japan Vasculitis Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 40. Japan Vasculitis Drug Revenue Share by Application (2015-2020)
Figure 41. Japan Vasculitis Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. North America Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Vasculitis Drug Sales Market Share by Country in 2019
Figure 45. North America Vasculitis Drug Revenue Market Share by Country in 2019
Figure 46. U.S. Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.S. Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Vasculitis Drug Sales Market Share by Country in 2019
Figure 53. Europe Vasculitis Drug Revenue Market Share by Country in 2019
Figure 54. Germany Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Vasculitis Drug Sales Market Share by Region in 2019
Figure 67. Asia Pacific Vasculitis Drug Revenue Market Share by Region in 2019
Figure 68. China Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. South Korea Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. India Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Australia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Taiwan Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Indonesia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Thailand Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Malaysia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Philippines Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Vietnam Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Vasculitis Drug Sales Market Share by Country in 2019
Figure 93. Latin America Vasculitis Drug Revenue Market Share by Country in 2019
Figure 94. Mexico Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Middle East and Africa Vasculitis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Vasculitis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Vasculitis Drug Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Vasculitis Drug Revenue Market Share by Country in 2019
Figure 104. Turkey Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Vasculitis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Vasculitis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Porter's Five Forces Analysis
Figure 111. Vasculitis Drug Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
Keyplayers in Global and Japan Vasculitis Drug Market Insights, Forecast to 2026
MerckBayer
Farmalider
Hainan Pharmaceutical Factory
Shanghaihuangxiang Lantian Pharmaceutical
Huzhou Konch Pharmaceutical
CSPC Ouyi Pharmaceutical
Sino-US Zibo Xinhua-Perrigo Pharmaceutical
Hubei Biocause Pharmaceutical